Patients with dyslipidemia
Conditions
Interventions
EPA: 1.8g/day for 24 weeks
EPA+DHA: 2g/day for 24 weeks
Sponsors
University of Shizuoka
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patient with dyslipidemia have already continued the treatment of statin more than three months, and curative effect is inadequate. (2) Patient who does not take EPA preparation, EPA+DHA preparation or a supplement containing DHA and EPA. (3) Patient at the agreement acquisition 20 years or older (4) The patient that a written agreement was provided by the free will of the person after enough understanding about The participation in this study
Exclusion criteria
Exclusion criteria: (1) The patient who having unstable angina before registration or has the myocardial infarction past of the onset for less than three months at registration (2) The patient who takes EPA preparation and EPA+DHA preparation (3) Hospitalized patient (4) The patient who has an allergy for a blue-skinned fish (5) During the pregnancy or the woman who is nursing it (6) It is the patients with in treatment or terminal cancer for a malignant tumor (7) When I judge a study responsibility doctor, a study allotment doctor not to be appropriate about the participation of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Carotid IMT-C10 | — |
Secondary
| Measure | Time frame |
|---|---|
| Carotid maxIMT, LDL-C, HDL-C, TG, nonHDL-C, EPA, DHA, AA, DHLA, LP(a), RLP-C SAA-LDL, AT-LDL | — |
Countries
Japan
Contacts
Public ContactTatsuya Morimoto
University of Shizuoka Division of Molecular Medicine, Graduate School of Pharmaceutical Sciences
Outcome results
None listed